Su SG - Search Results

1

CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma.

Yang YF, Pan YH, Tian QH, Wu DC, Su SG. Yang YF, et al. Among authors: su sg. Transl Oncol. 2018 Oct;11(5):1110-1118. doi: 10.1016/j.tranon.2018.07.002. Epub 2018 Jul 19. Transl Oncol. 2018. PMID: 30031230 Free PMC article.

2

[High expression of nucleophosmin/B23 in hepatocellular carcinoma].

Tian QH, Yun JP, Miao J, Chen G, Fu J, Zhang CQ, Su SG, Zhang MF, Wu QL. Tian QH, et al. Among authors: su sg. Zhonghua Bing Li Xue Za Zhi. 2006 Jul;35(7):407-11. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 17069676 Chinese.

3

BLZF1 expression is of prognostic significance in hepatocellular carcinoma.

Huang RY, Su SG, Wu DC, Fu J, Zeng X. Huang RY, et al. Among authors: su sg. Biochem Biophys Res Commun. 2015 Nov 20;467(3):602-9. doi: 10.1016/j.bbrc.2015.08.119. Epub 2015 Sep 2. Biochem Biophys Res Commun. 2015. PMID: 26342799

4

Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment.

Yang YF, Liao YY, Liu XL, Su SG, Li LZ, Peng NF. Yang YF, et al. Among authors: su sg. Gynecol Oncol. 2015 Dec;139(3):419-23. doi: 10.1016/j.ygyno.2015.10.015. Epub 2015 Oct 19. Gynecol Oncol. 2015. PMID: 26494424

5

HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinoma.

Wu DC, Zhang MF, Su SG, Fang HY, Wang XH, He D, Xie YY, Liu XH. Wu DC, et al. Among authors: su sg. Oncotarget. 2016 Jun 21;7(25):38052-38063. doi: 10.18632/oncotarget.9343. Oncotarget. 2016. PMID: 27191260 Free PMC article.

6

miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.

Su SG, Yang M, Zhang MF, Peng QZ, Li MY, Liu LP, Bao SY. Su SG, et al. Int J Biochem Cell Biol. 2017 Oct;91(Pt A):53-59. doi: 10.1016/j.biocel.2017.08.016. Epub 2017 Sep 1. Int J Biochem Cell Biol. 2017. PMID: 28867541

7

UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.

Pan YH, Yang M, Liu LP, Wu DC, Li MY, Su SG. Pan YH, et al. Among authors: su sg. Biochem Biophys Res Commun. 2018 Sep 5;503(2):895-902. doi: 10.1016/j.bbrc.2018.06.093. Epub 2018 Jun 20. Biochem Biophys Res Commun. 2018. PMID: 29928880

8

ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancer.

Guo XB, Huang B, Pan YH, Su SG, Li Y. Guo XB, et al. Among authors: su sg. Cancer Manag Res. 2018 Nov 22;10:6157-6166. doi: 10.2147/CMAR.S181265. eCollection 2018. Cancer Manag Res. 2018. PMID: 30538563 Free PMC article.

9

An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular Carcinoma.

Su SG, Li QL, Zhang MF, Zhang PW, Shen H, Zhang CZ. Su SG, et al. Front Oncol. 2021 Feb 5;10:593293. doi: 10.3389/fonc.2020.593293. eCollection 2020. Front Oncol. 2021. PMID: 33614480 Free PMC article.

10

PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosis.

Jiang N, Li QL, Pan W, Li J, Zhang MF, Cao T, Su SG, Shen H. Jiang N, et al. Among authors: su sg. Int J Biochem Cell Biol. 2020 Mar;120:105681. doi: 10.1016/j.biocel.2019.105681. Epub 2019 Dec 26. Int J Biochem Cell Biol. 2020. PMID: 31884111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters